Tr1X Inc. (pr. "Trix")  is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its proprietary platform for the generation of first-in-class cell therapy products aimed at rebalancing the immune system and restoring homeostasis, leading to long term tolerance. Tr1X is headquartered in La Jolla, CA.

Tr1X 

DiaCarta is a company that provides precision molecular diagnostics and epigenetics services for cancer research and clinical applications.

DiaCarta

Mission Bio is a company that develops and commercializes innovative tools for high-impact applications in oncology research and precision medicine.

Mission Bio

Quadrants Scientific is a company that specializes in providing scientific and laboratory equipment, supplies, and services to the biotechnology and healthcare industries.

Quadrants Scientific

TR1X Bio is a company focused on delivering innovative solutions in the healthcare and biotechnology sector. The company leverages cutting-edge technology and research to develop products and services that aim to improve patient outcomes and healthcare efficiency.

TR1X Bio

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 12, 2024 3:38 AM	b739f53f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	bbfab2bf
crunchbase profile	general
li profile	general	May 12, 2024 3:38 AM	e383e34d
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 3:38 AM	8b5693f6
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:TR1X

TR1X Bio